Procedure overviewStart with diagnosis and purpose.
ABO-incompatible kidney transplantation may allow a suitable living donor whose blood group is not conventionally compatible. A specialist programme uses antibody assessment and a planned desensitisation strategy to reduce the risk of antibody-mediated rejection; it is not appropriate for every recipient–donor pair.
ABO-Incompatible Kidney Transplant is a named clinical pathway, but the name alone does not define the exact treatment. Technique, complexity, expected benefit and recovery depend on the individual findings and the hospital team’s assessment.
A useful preliminary review should clarify what diagnosis is established, why this procedure is being considered, whether further tests are needed, what alternatives exist and which parts of the plan remain provisional until examination.
No outcome can be guaranteed.Ask the treating clinician to explain patient-specific benefits, material risks, uncertainty and what may happen without treatment.